· Volume surge · NVO
Novo Nordisk A/S (NVO) extends 30.0% 12-week advance as activity picks up
The healthcare heavyweight is recovering on weekly data, but the setup still lacks clean trend confirmation.
Novo Nordisk A/S (NVO) closed the latest week at 48.07 USD, rising 11.3% and adding to a 5.5% four-week gain.
The evidence is mixed beneath the advance. Active-mover volume flagged heavier participation, but Relative Strength stayed negative and the trend signal remained inactive even as Market Dynamics showed positive pressure.
The chart is a weekly price path over 52 weeks, so it frames the move as weekly context rather than live intraday action.